Study of Blinking as a Function of Tear Film Quality
WINK
Etude Des Clignements en Fonction de la Qualité du Film Lacrymal
2 other identifiers
interventional
60
1 country
1
Brief Summary
The goal of this study is to better understand how eye blinking behavior is linked to the stability of the tear film, in adults aged 18 to 65 years, with or without symptoms of dry eye. The main questions are:
- Do the results of a New Blink Task reflect tear film stability ?
- How are the blink related metrics in relation with each other? Researchers will compare two groups of participants-those without dry eye symptoms and those with dry eye symptoms-to see if blinking measures differ between them and whether these measures relate differently to tear film quality. Participants will:
- Answer a questionnaire about dry eye symptoms
- Have their visual correction measured (if they wear glasses)
- Undergo non-invasive assessments of tear film quality using an imaging device
- Complete three types of blink tasks, each repeated three times, including measurements of blinking and of tear film stability
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
March 17, 2026
CompletedFirst Posted
Study publicly available on registry
March 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
March 30, 2026
March 1, 2026
3 months
March 17, 2026
March 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluates the correlation between the Absolute Maximum Eye Aperture Duration measured in seconds and the non-invasive tear film break-up time measured in seconds measured with device IDRA .
Day one
Secondary Outcomes (4)
Evaluates the correlation between the Absolute Maximum Eye Aperture Duration measured in seconds with parameters of dry eye ( tears meniscus height (mm), bulbar redness grade (from 0 to 4), blink quality (in %)) measured with device IDRA .
Day one
Compares the coefficient of variation of the Absolute Maximum Eye Aperture Duration (in %) with the coefficient of variation of the non-invasive tear film break-up time (in %) measured with device IDRA .
Day one
Evaluate the effects of ocular surface characteristics, demographics, and task acceptability on two primary outcomes via linear regression model
Day one
Evaluate the effects of ocular surface characteristics, demographics, and task acceptability on coefficient of variation of two primary outcomes via linear regression model
Day one
Study Arms (1)
Single arm
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Volunteer, fluent in French, willing to follow the protocol, able to read and understand the information sheet and provide free and informed consent
- Covered by a social security
- Aged between 18 and 65 years inclusive
- Binocular near visual acuity ≤ 0.3 LogMAR (≥ 5/10) (corrective glasses accepted)
You may not qualify if:
- Employees of Essilor International, Luxottica, or GrandVision and their subsidiaries
- Pregnant or breastfeeding women (Article L1121-5)
- Individuals deprived of liberty by judicial or administrative decision, or hospitalized without consent under Articles L.3212-1 and L.3213-1, who do not fall under Article L.1121-8, and individuals admitted to a health or social care facility for purposes other than research
- Adults unable or incapable of giving informed consent (Article L1121-8)
- Participants deemed unfit to participate by the investigator for any reason that may affect subject safety or study integrity All categories of individuals particularly protected under French law are excluded from this research (Articles L1121-5 to L1121-9 of the French Public Health Code).
- Use of eye drops or ophthalmic solutions within the last 2 hours
- Wearing contact lenses within the last 48 hours
- Reported history of eye surgery or trauma to the eye or its adnexa excepted refractive surgery and cataract surgery
- Reported history of eyelid abnormalities (ptosis)
- Reported history of neurological deficits, including epilepsy or sensory-motor coordination disorders, vestibular or cerebellar pathology (e.g., balance disorders, nystagmus, Parkinson's disease)
- Reported history of musculoskeletal disorders preventing maintenance of a fixed head position
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
EssilorLuxottica - Neuroscience & Medical Research center
Paris, 94220, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 17, 2026
First Posted
March 30, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
March 30, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share